Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome

S Villapol - Translational Research, 2020 - Elsevier
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the
greatest worldwide pandemic since the 1918 flu. The consequences of the coronavirus …

Body localization of ACE-2: on the trail of the keyhole of SARS-CoV-2

F Salamanna, M Maglio, MP Landini, M Fini - Frontiers in medicine, 2020 - frontiersin.org
The explosion of the new coronavirus (SARS-CoV-2) pandemic has brought the role of the
angiotensin converting enzyme 2 (ACE2) back into the scientific limelight. Since SARS-CoV …

Racial and gender-based differences in COVID-19

J Kopel, A Perisetti, A Roghani, M Aziz… - Frontiers in public …, 2020 - frontiersin.org
The novel coronavirus disease (COVID-19) has become a global health crisis since its first
appearance in Wuhan, China. Current epidemiological studies suggest that COVID-19 …

The potential application of probiotics and prebiotics for the prevention and treatment of COVID-19

AN Olaimat, I Aolymat, M Al-Holy, M Ayyash… - npj Science of …, 2020 - nature.com
COVID-19 is a pandemic disease caused by the novel coronavirus severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). This new viral infection was first identified in China …

Pulmonary and extra-pulmonary clinical manifestations of COVID-19

KD Johnson, C Harris, JK Cain, C Hummer… - Frontiers in …, 2020 - frontiersin.org
The severe acute respiratory syndrome coronavirus− 2 (SARS-CoV-2) has been recently
identified as the culprit of the highly infectious, outbreak named coronavirus disease 2019 …

Gut microbiota status in COVID-19: an unrecognized player?

S Donati Zeppa, D Agostini, G Piccoli… - Frontiers in cellular …, 2020 - frontiersin.org
Infection with the SARS-CoV-2 virus causes cardiopulmonary and vascular complications,
ranging in severity. Understanding the pathogenic mechanisms of the novel SARS-CoV2 …

Gastrointestinal symptoms and outcomes in hospitalized coronavirus disease 2019 patients

P Ramachandran, I Onukogu, S Ghanta… - Digestive …, 2020 - karger.com
Introduction: Gastrointestinal (GI) symptoms are increasingly being recognized in
coronavirus disease 2019 (COVID-19). It is unclear if the presence of GI symptoms is …

[HTML][HTML] Liver injury in the era of COVID-19

H Cichoż-Lach, A Michalak - World journal of gastroenterology, 2021 - ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has undoubtedly
revolutionized the whole globe and given a new point of view on respiratory tract infections …

Coronavirus disease (COVID-19) caused by (SARS-CoV-2) infections: a real challenge for human gut microbiota

DC Vodnar, L Mitrea, BE Teleky, K Szabo… - Frontiers in cellular …, 2020 - frontiersin.org
The current COVID-19 pandemic is a great challenge for worldwide researchers in the
human microbiota area because the mechanisms and long-term effects of the infection at the …

Cannabidiol inhibits SARS‐Cov‐2 spike (S) protein‐induced cytotoxicity and inflammation through a PPARγ‐dependent TLR4/NLRP3/Caspase‐1 signaling …

C Corpetti, A Del Re, L Seguella, I Palenca… - Phytotherapy …, 2021 - Wiley Online Library
Given the abundancy of angiotensin converting enzyme 2 (ACE‐2) receptors density,
beyond the lung, the intestine is considered as an alternative site of infection and replication …